+8%

est. 2Y upside i

InsurTechSeries D+

Rank

#1860

Sector

Insurtech

Est. Liquidity

~2Y

Data Quality

Data: High

Despite 53% revenue growth and a recent $6.3B valuation, the expected 2-year equity upside is only ~8% due to high bear-case probability (45%) from incumbent threats and capital intensity.

Last updated: July 3, 2026

Bull (20%)+84%

Revenue grows to $1.66B by 2028, exit multiple holds at 7x due to successful IPO in 2027 and category leadership in digital health insurance. Implies market cap ~$11.6B.

Base (35%)+19%

Revenue reaches $1.66B, exit multiple converges to 4.5x in line with public insurtech comps. Market cap ~$7.5B, upside 18.6%.

Bear (45%)-34%

Revenue growth slows more than expected, multiple compresses to 2.5x as competitive pressure from incumbents and capital intensity weigh. Market cap ~$4.15B, downside -34.1%.

Est. time to liquidity~2.0 years

Preference Stack Risk

high

Funding Intensity

2095%

Total funding of $1.32B represents ~21% of current valuation, creating a high preference overhang that dilutes common equity in downside scenarios.

Dilution Risk

moderate

Alan raised $550M in June 2026, providing ample runway; however, high capital intensity may require additional funding pre-IPO, leading to moderate dilution.

Secondary Liquidity

none

No secondary market transactions reported; liquidity expected at IPO or acquisition.

Engineering — 26 roles

Sales 🇫🇷 — 17 roles

Marketing — 10 roles

Care 🇫🇷 — 3 roles

Operations — 3 roles

Sales 🇪🇸 — 3 roles

Business Strategy & Operations — 2 roles

Corporate — 2 roles

Insurance — 2 roles

Sales 🇨🇦 — 2 roles

Work Environment — 2 roles

Care 🇧🇪 — 1 role

Design & Research — 1 role

  • Product Designer · Paris, France; Bordeaux, France; Marseille, France; Brussels, Belgium; Madrid, Spain; Barcelona, Spain

People — 1 role

Product — 1 role

View all 91 open roles at Alan →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Alan's data — designed to show you've done your homework.

  • 1

    “How will Alan differentiate from incumbents like AXA and Allianz?”

  • 2

    “What are the unit economics and customer acquisition costs?”

  • 3

    “What is the expected timeline to an IPO and how does the stock option pool size impact dilution?”

Community

Valuation Sentiment

Our model estimates +8% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.